Free shipping on all orders over $ 500

(+)-DHMEQ

Cat. No. M14591
(+)-DHMEQ Structure
Synonym:

(1R,2R,6R)-Dehydroxymethylepoxyquinomicin; (1R,2R,6R)-DHMEQ

Size Price Availability
5mg USD 275  USD275 1-2 Weeks
10mg USD 375  USD375 1-2 Weeks
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

(+)-DHMEQ is an activator of antioxidant transcription factor Nrf2. (+)-DHMEQ is the enantiomer of (-)-DHMEQ. (-)-DHMEQ inhibits NF-kB than its enantiomer (+)-DHMEQ.

Chemical Information
Molecular Weight 261.23
CAS Number 287194-41-6
Solubility (25°C) DMSO 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Marcin Michalak, et al. DHMEQ enhances the cytotoxic effect of cisplatin and carboplatin in ovarian cancer cell lines

[2] Jun Ma, et al. Inhibition of Cellular and Animal Inflammatory Disease Models by NF-κB Inhibitor DHMEQ

[3] Yinzhi Lin, et al. The designed NF-κB inhibitor, DHMEQ, inhibits KISS1R-mediated invasion and increases drug-sensitivity in mouse plasmacytoma SP2/0 cells

[4] Kazuo Umezawa, et al. Anticancer Activity of Novel NF-kappa B Inhibitor DHMEQ by Intraperitoneal Administration

[5] Yinzhi Lin, et al. Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review

Related Keap1-Nrf2 Products
TAT-14

TAT-14 is a 14-mer peptide that acts as Nrf2 activator with an anti-inflammatory effect.

[D-Asp3]-Microcystin-LR

Microcystin-[D-Asp3]-LR/Microcystin A is a cyanotoxin.

Keap1-Nrf2 probe

Keap1-Nrf2 probe is a fluorescent Keap1-Nrf2 probe.

BAY-3605349

BAY-3605349 is an orally active Kelch-like ECH-associated protein 1 (KEAP1) activator as well as Nrf2 inhibitor for tumor-related studies.

Nrf2/HO-1 activator 1

Nrf2/HO-1 activator 1 is a potent Nrf2/HO-1 activator, neuroprotective agent.

  Catalog
Abmole Inhibitor Catalog




Keywords: (+)-DHMEQ, (1R,2R,6R)-Dehydroxymethylepoxyquinomicin; (1R,2R,6R)-DHMEQ supplier, Keap1-Nrf2, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.